“…In previous study we have demonstrated that the myeloprotective properties of several natural and synthetic compounds are partially responsible for their antitumour activity in the Ehrlich ascites tumour model [16,17,20]. Clonogenic studies in EAT-inoculated mice demonstrated a rapid decrease in bone marrow CFU-GM, whereas a progressive increase in splenic CFU-GM and cellularity was observed, followed by splenomegally [10].…”